@Deciphera

Deciphera, a member of Ono Pharmaceutical Co., Ltd., is a biopharmaceutical company focused on developing and delivering novel, innovative medicines to patients

deciphera.com/
Joined October 2017
  • Tweets489
  • Following169
  • Followers857
本日（7月31日）、2027年3月期第1四半期 決算発表を行いました。 詳細は以下のURLをご覧ください。 ※株主・投資家向けのページです ono-pharma.com/ja/ir/library…
2
1
13
1,530
Deciphera Pharma retweeted
ASCO
@ASCO
25 Jan 2022
Join us for the #ASCOPlenarySeries session TODAY @ 3 PM ET as Dr. Michael C. Heinrich presents on ripretinib vs sunitinib in #GIST. Faculty: @GeorgeSledge51  @VKeedySarcomaMD Dr. Heinrich @GistLab @OHSUNews  @DrSarcoma View program ➡️ fal.cn/3lBVk #sarcoma #gicsm
4
1
10
Last up for the day is Timothy M. Caldwell, Principal Investigator from Deciphera Pharmaceuticals. He’s talking about clinical candidate DCC-3014, aka vimseltinib, a potential cancer treatment that targets colony-stimulating factor 1 receptor (CSF1R) kinase. #ACSSpring2021
1
3
5
Save the date for this informative webinar about the @Deciphera Intrigue Trial.liferaftgroup.org/event/unde…
2
2
Deciphera Pharma retweeted
Cancer Cell@Cancer_Cell
13 May 2019
Flynn @Deciphera & colleagues develop ripretinib, a kinase inhibitor of a broad spectrum of oncogenic and drug-resistant KIT and PDGFRA variants, which shows efficacy in preclinical cancer models and reduces circulating tumor DNA in GIST patients cell.com/cancer-cell/fulltex…
5
2
9
Deciphera Pharma retweeted
Deciphera Pharma
@Deciphera
18 Dec 2017
Proud $DCPH was added to Russell 2000 index. Read more: investors.deciphera.com/node…
2
Load more